GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinco Pharmaceutical Holdings Ltd (HKSE:06833) » Definitions » 5-Year Yield-on-Cost %

Sinco Pharmaceutical Holdings (HKSE:06833) 5-Year Yield-on-Cost % : 4.15 (As of May. 16, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sinco Pharmaceutical Holdings 5-Year Yield-on-Cost %?

Sinco Pharmaceutical Holdings's yield on cost for the quarter that ended in Dec. 2023 was 4.15.


The historical rank and industry rank for Sinco Pharmaceutical Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:

HKSE:06833' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.41   Med: 0.6   Max: 4.39
Current: 4.15


During the past 10 years, Sinco Pharmaceutical Holdings's highest Yield on Cost was 4.39. The lowest was 0.41. And the median was 0.60.


HKSE:06833's 5-Year Yield-on-Cost % is ranked better than
61.9% of 63 companies
in the Medical Distribution industry
Industry Median: 3.41 vs HKSE:06833: 4.15

Competitive Comparison of Sinco Pharmaceutical Holdings's 5-Year Yield-on-Cost %

For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinco Pharmaceutical Holdings's 5-Year Yield-on-Cost % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Sinco Pharmaceutical Holdings's 5-Year Yield-on-Cost % falls into.



Sinco Pharmaceutical Holdings 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Sinco Pharmaceutical Holdings is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Sinco Pharmaceutical Holdings  (HKSE:06833) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Sinco Pharmaceutical Holdings 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinco Pharmaceutical Holdings (HKSE:06833) Business Description

Traded in Other Exchanges
N/A
Address
No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN
Sinco Pharmaceutical Holdings Ltd is an investment holding company engaged in the provision of comprehensive marketing, promotion, and channel management service for imported pharmaceutical products and medical devices in China. The company has three operating segments; the sale of imported pharmaceutical products segment, the research and manufacturing of aesthetic medicine segment, and the medical beauty services segment. Its product offering includes Human albumin solutions and Antibiotics like Axetine and Medocef.

Sinco Pharmaceutical Holdings (HKSE:06833) Headlines

No Headlines